JAMES MCNUTT: Open Payments
NPI 1790088623 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,293 in 178 payments from 24 companies in 2025. Trend: 2023 $159 · 2024 $759 · 2025 $5,293
Food & beverage: $3,681Consulting: $1,434Education: $178
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $2,018 |
| GlaxoSmithKline, LLC. | 29 | $477 |
| Insmed, Inc. | 36 | $422 |
| AstraZeneca Pharmaceuticals LP | 20 | $421 |
| ABBVIE INC. | 10 | $228 |
| Amgen Inc. | 11 | $196 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $177 |
| Grifols USA, LLC | 7 | $157 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $149 |
| Actelion Pharmaceuticals US, Inc. | 4 | $139 |
Products named: DUPIXENT, Arikayce, NUCALA, TEZSPIRE, AIRSUPRA, GLASSIA, Prolastin-C Liquid, WAKIX.
Industry payments across FL — which companies pay providers there.
